Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 20.78
-0.33 (-1.56%)
Jun 18, 2026, 3:00 PM CST
SHA:600332 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600332 stock has a consensus rating of "Hold" and an average price target of ¥25.80. The average 1-year stock price forecast is 24.16% higher than the current stock price, while the lowest is ¥17.60 (-15.30%) and the highest is ¥34.00 (+63.62%).
Price Target: ¥25.80 (+24.16%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SHA:600332 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Oct '25 | Dec '25 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 2 | 2 |
Financial Forecast
Revenue This Year
81.73B
from 77.66B
Increased by 5.24%
Revenue Next Year
85.11B
from 81.73B
Increased by 4.15%
EPS This Year
1.92
from 1.45
Increased by 32.06%
EPS Next Year
2.00
from 1.92
Increased by 4.18%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 82.1B | ||
| Avg | 81.7B | ||
| Low | 81.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.7% | ||
| Avg | 5.2% | ||
| Low | 5.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.92 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 32.1% | ||
| Low | - |